v3.25.0.1
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 7 $ 501,893 $ (471,728) $ 30,172
Balance, shares at Dec. 31, 2021 7,475,916      
Net loss (29,885) (29,885)
Common stock issued in conjunction with exercise of stock options 13 13
Common stock issued in conjunction with exercise of stock options, shares 1,533      
Common stock and warrants issued in conjunction with follow-on public offering, net of issuance costs $ 1 4,265 4,266
Common stock and warrants issued in conjunction with follow-on public offering, net of issuance costs, shares 800,000      
Common stock issued for vested restricted stock awards 362 362
Common stock issued for vested restricted stock awards, shares 28,877      
Stock-based compensation expense 2,051 2,051
Balance at Dec. 31, 2022 $ 8 508,584 (501,613) 6,979
Balance, shares at Dec. 31, 2022 8,306,326      
Net loss (6,578) (6,578)
Stock-based compensation expense 396 396
Common stock issued under 2023 At-the-Market Offering Agreement, net of issuance costs 30 30
Common stock issued under At-the-Market Offering Agreement, net of issuance costs, shares 23,217      
Balance at Mar. 31, 2023 $ 8 509,010 (508,191) 827
Balance, shares at Mar. 31, 2023 8,329,543      
Balance at Dec. 31, 2022 $ 8 508,584 (501,613) 6,979
Balance, shares at Dec. 31, 2022 8,306,326      
Net loss       (13,601)
Balance at Sep. 30, 2023 $ 11 514,544 (515,214) (659)
Balance, shares at Sep. 30, 2023 10,287,182      
Balance at Dec. 31, 2022 $ 8 508,584 (501,613) 6,979
Balance, shares at Dec. 31, 2022 8,306,326      
Net loss (16,690) (16,690)
Common stock issued for vested restricted stock awards $ 1 814 815
Common stock issued for vested restricted stock awards, shares 199,699      
Stock-based compensation expense 909 909
Common stock issued under 2023 At-the-Market Offering Agreement, net of issuance costs 68 68
Common stock issued under At-the-Market Offering Agreement, net of issuance costs, shares 35,552      
Common stock issued under 2023 Equity Line of Credit Agreement, net of issuance costs 1,177 1,177
Common stock issued under Equity Line of Credit Agreement, net of issuance costs, shares 360,943      
Common stock issued for entering into 2023 Equity Line of Credit Agreement 258 258
Common stock issued for entering into Equity Line of Credit Agreement, shares 47,733      
Common stock issued under 2023 Direct Offering, net of issuance costs $ 2 4,117 4,119
Common stock issued under Direct Offering, net of issuance costs, shares 1,694,820      
Fractional shares adjustment related to reverse stock split
Fractional shares adjustment related to reverse stock split, shares (24)      
Balance at Dec. 31, 2023 $ 11 515,927 (518,303) (2,365)
Balance, shares at Dec. 31, 2023 10,645,049      
Balance at Mar. 31, 2023 $ 8 509,010 (508,191) 827
Balance, shares at Mar. 31, 2023 8,329,543      
Net loss (2,317) (2,317)
Common stock issued for vested restricted stock awards $ 1 263 264
Common stock issued for vested restricted stock awards, shares 30,441      
Stock-based compensation expense 224 224
Common stock issued under 2023 At-the-Market Offering Agreement, net of issuance costs 38 38
Common stock issued under At-the-Market Offering Agreement, net of issuance costs, shares 12,335      
Common stock issued under 2023 Equity Line of Credit Agreement, net of issuance costs 178 178
Common stock issued under Equity Line of Credit Agreement, net of issuance costs, shares 53,335      
Common stock issued for entering into 2023 Equity Line of Credit Agreement 258 258
Common stock issued for entering into Equity Line of Credit Agreement, shares 47,733      
Fractional shares adjustment related to reverse stock split
Fractional shares adjustment related to reverse stock split, shares (24)      
Balance at Jun. 30, 2023 $ 9 509,971 (510,508) (528)
Balance, shares at Jun. 30, 2023 8,473,363      
Net loss (4,706) (4,706)
Common stock issued for vested restricted stock awards 421 421
Common stock issued for vested restricted stock awards, shares 118,999      
Stock-based compensation expense (3) (3)
Common stock issued under 2023 Direct Offering, net of issuance costs $ 2 4,155 4,157
Common stock issued under Direct Offering, net of issuance costs, shares 1,694,820      
Balance at Sep. 30, 2023 $ 11 514,544 (515,214) (659)
Balance, shares at Sep. 30, 2023 10,287,182      
Balance at Dec. 31, 2023 $ 11 515,927 (518,303) (2,365)
Balance, shares at Dec. 31, 2023 10,645,049      
Net loss (4,629) (4,629)
Common stock issued for vested restricted stock awards
Common stock issued for vested restricted stock awards, shares 16,686      
Stock-based compensation expense 362 362
Common stock issued under 2023 Equity Line of Credit Agreement, net of issuance costs 400 400
Common stock issued under Equity Line of Credit Agreement, net of issuance costs, shares 111,369      
Common stock issued under 2023 Direct Offering, net of issuance costs $ 1 4,868 4,869
Common stock issued under Direct Offering, net of issuance costs, shares 1,371,000      
Warrant Exercise
Warrant Exercise, shares 200,000      
Balance at Mar. 31, 2024 $ 12 521,557 (522,932) (1,363)
Balance, shares at Mar. 31, 2024 12,344,104      
Balance at Dec. 31, 2023 $ 11 515,927 (518,303) (2,365)
Balance, shares at Dec. 31, 2023 10,645,049      
Net loss       (11,706)
Balance at Sep. 30, 2024 $ 16 527,473 (530,009) (2,520)
Balance, shares at Sep. 30, 2024 16,284,381      
Balance at Mar. 31, 2024 $ 12 521,557 (522,932) (1,363)
Balance, shares at Mar. 31, 2024 12,344,104      
Net loss (3,530) (3,530)
Common stock issued for vested restricted stock awards 16 16
Common stock issued for vested restricted stock awards, shares 5,000      
Stock-based compensation expense 106 106
Common stock issued under 2023 Equity Line of Credit Agreement, net of issuance costs $ 1 1,100 1,101
Common stock issued under Equity Line of Credit Agreement, net of issuance costs, shares 475,986      
Issuance costs related to common stock issued under 2024 Direct Offering (39) (39)
Balance at Jun. 30, 2024 $ 13 522,740 (526,462) (3,709)
Balance, shares at Jun. 30, 2024 12,825,090      
Net loss (3,547) (3,547)
Common stock issued for vested restricted stock awards 145 145
Common stock issued for vested restricted stock awards, shares 127,701      
Stock-based compensation expense 235 235
Common stock issued under 2023 Equity Line of Credit Agreement, net of issuance costs 400 400
Common stock issued under Equity Line of Credit Agreement, net of issuance costs, shares 362,219      
Common stock issued under Warrant Inducement Agreement, net of issuance costs $ 2 1,860 1,862
Common stock issued under Warrant Inducement Agreement, net of issuance costs, shares 1,711,111      
Reclassification of Warrant Liability upon Exercise 245 245
Common stock issued under 2024 Private Placement Offering, net of issuance costs $ 1 1,837 1,838
Common stock issued under Private Placement Offering, net of issuance costs, shares 1,248,527      
Common stock issued under 2024 Securities Purchase Agreements 11 11
Common stock issued under Securities Purchase Agreements, shares 9,733      
Balance at Sep. 30, 2024 $ 16 $ 527,473 $ (530,009) $ (2,520)
Balance, shares at Sep. 30, 2024 16,284,381